STOCK TITAN

WRAP Technologies grants director 30,000 stock options

The options have a stated expiration date of October 20, 2036.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

WRAP Technologies, Inc. director Edward Delatorre Jr. received an option grant to purchase up to 30,000 shares of common stock at an exercise price of $1.45 per share. Fifteen thousand shares vest on October 20, 2027, and 3,750 shares vest quarterly on January 20, April 20, July 20 and October 20, 2028, subject to his continuing service on each vesting date. The options expire October 20, 2036.

Insider Delatorre Edward JR
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to purchase) F1, F2 30,000 $0.00 $0.00
Holdings After Transaction: Stock Option (right to purchase) — 30,000 contracts (Direct)
Footnotes (2)
  1. F1. On October 20, 2026 (the "Grant Date"), Mr. Delatorre was granted an option to purchase up to thirty thousand (30,000) shares of common stock ("Shares") following his appointment to the Board of Directors of Wrap Technologies, Inc. (the "Issuer") (the "Option Grant"). Fifteen thousand (15,000) Shares shall vest in twelve (12) months on October 20, 2027, and three-thousand seven-hundred and fifty (3,750) Shares shall vest on a quarterly basis on each of January 20, 2028, April 20, 2028, July 20, 2028 and October 20, 2028, subject to Mr. Delatorre's continuing service to the Issuer on each applicable vesting date.
  2. F2. Fifty percent (50%) of the Option Grant shall vest twelve (12) months after the Grant Date and the remaining fifty percent (50%) of the Option Grant shall vest equally at the end of each quarter thereafter, subject to Mr. Delatorre's continuing service to the Issuer on each applicable vesting date.
Option grant 30,000 options to purchase common shares Granted October 20, 2026
Exercise price $1.45 per share Option grant
First vesting tranche 15,000 shares Vests October 20, 2027, subject to continuing service
Quarterly vesting tranche 3,750 shares Each quarter on January 20, April 20, July 20 and October 20, 2028, subject to continuing service
Option expiration October 20, 2036 Expiration date
Stock Option (right to purchase) technical
"Stock Option (right to purchase)"
Grant Date technical
"the "Grant Date""
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vest technical
"Shares shall vest in twelve (12) months"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WRAP options did director Edward Delatorre receive?

Edward Delatorre Jr. received an option grant to purchase up to 30,000 shares of WRAP common stock, with an exercise price of $1.45 per share.

When do Edward Delatorre's WRAP options vest?

15,000 shares vest on October 20, 2027, and 3,750 shares vest on each of January 20, April 20, July 20 and October 20, 2028. Vesting is subject to his continuing service on each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Delatorre Edward JR

(Last)(First)(Middle)
C/O WRAP TECHNOLOGIES, INC.
3350 VIRGINIA STREET

(Street)
MIAMI FLORIDA 33133

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
WRAP TECHNOLOGIES, INC. [ WRAP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to purchase)(1)$1.4510/20/2026A30,000 (2)10/20/2036Common Stock30,000$030,000D
Explanation of Responses:
1. On October 20, 2026 (the "Grant Date"), Mr. Delatorre was granted an option to purchase up to thirty thousand (30,000) shares of common stock ("Shares") following his appointment to the Board of Directors of Wrap Technologies, Inc. (the "Issuer") (the "Option Grant"). Fifteen thousand (15,000) Shares shall vest in twelve (12) months on October 20, 2027, and three-thousand seven-hundred and fifty (3,750) Shares shall vest on a quarterly basis on each of January 20, 2028, April 20, 2028, July 20, 2028 and October 20, 2028, subject to Mr. Delatorre's continuing service to the Issuer on each applicable vesting date.
2. Fifty percent (50%) of the Option Grant shall vest twelve (12) months after the Grant Date and the remaining fifty percent (50%) of the Option Grant shall vest equally at the end of each quarter thereafter, subject to Mr. Delatorre's continuing service to the Issuer on each applicable vesting date.
/s/ Edward Delatorre, Jr.10/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading